- 9 Erkang Road, Liuyang Economic and Technological Development Zone, Changsha City, Hunan Province
- Sales@erkangpharma.com
- +86 731 8579 6471 (Office landline)
Menu
Hunan Er-kang Pharmaceutical Co., Ltd., founded in 2003, is the largest and most comprehensive pharmaceutical excipient company in China, boasting the widest range of products and the most advanced technology (Stock Code: SZ.300267). It is a leading enterprise in the high-tech sector and a pioneer in the pharmaceutical excipient industry, being the primary architect of China’s pharmaceutical excipient standards and the first to industrialize starch capsules. The company currently offers 127 types of pharmaceutical excipients, 73 active pharmaceutical ingredients (APIs), and has 282 approvals for finished drug products. Among these, the starch-based plant capsule is a core product with global exclusive intellectual property rights, holding over 90 patents. The company’s products are exported to nearly 40 countries and regions worldwide. Erkang has received multiple accolades, including being named a ‘National Torch Program Key High-tech Enterprise’, ‘China’s Most Investment-worthy Pharmaceutical Listed Company’, ‘Top 100 Enterprises in China’s Pharmaceutical Industry’, and inclusion in the ‘Xinhua News Agency National Brand Project’.
In 2013, to further its internationalization strategy, Hunan Erkang (Cambodia) Investment Co., Ltd. established an industrial park, underpinned by the principles of ‘Innovation, Efficiency, and Environmental Protection’. With a cumulative investment of 2 billion yuan and spanning 2,000 acres, the park employs nearly 1,000 Cambodian-Chinese staff. Phoenix Industries, a wholly-owned subsidiary of Erkang, is located within the park. With over 300 Cambodian-Chinese employees, Phoenix Industries operates several state-of-the-art production workshops, boasting an annual capacity of 11,000 tons of caffeine, 1,000 tons of folic acid, and 30,000 tons of sodium citrate.
Looking ahead, Erkang Pharmaceutical will remain steadfast in its commitment to the pharmaceutical industry, focusing on the safety of drugs and food. The company will actively forge a new integrated pattern of ‘Intermediates + APIs + Formulations’, aiming to establish a national brand with international influence.
We create more marketable products for you with our expertise in dietary supplement, pharmaceuticals, additives and ingredients field.
A pioneering Chinese company in pharmaceutical APIs and excipients, achieving the first industrialization of starch capsules
Produced under the world's strictest cGMP standards
Certified by the highest level research center in China with state-of-the-art imported detection equipment
Over 70 years of pharmaceutical history as a listed company with over 200 patented inventions authorized for R&D
5,000 tons of starch glue
100 billion starch capsules
40,000 tons of modified starch
180,000 tons of tapioca starch
Our production processes effectively reduce energy consumption, enhance production efficiency, minimize environmental pollution, and truly achieve the goals of clean production.
We have obtained multiple international authoritative certifications, including NSF-GMP, ISO 22000, Non-GMO Verification, Vegetarian Society approval, KOF-K KOSHER, and JAKIM Halal. Our technological research and development and patent applications for formulas are at the forefront of international standards.
Some Cooperation Cases
Everything for the safety of medicine and food. In the future, we remain committed and continue our tireless efforts!
In October 2003，Erkang Pharmaceutical's journey began with its registration.
In 2005, the company's R&D department was officially established.
In 2006，following the 'Qi Er Yao Incident', the company entered a period of rapid growth.
In 2008, it was recognized as a High-Tech Enterprise in Hunan Province.
On September 27, 2011, Erkang Pharmaceutical was listed on the Shenzhen Stock Exchange.
In 2012, the company was successfully included in the National Torch Program Key High-Tech Enterprises. The 'National Pharmaceutical Excipient Engineering Technology Research Center' project received approval from the Ministry of Science and Technology, establishing the first national-level research platform.
In 2013, the company passed the certification for the new national GMP standards (2010 edition) and successfully developed starch-based capsules and soft capsules, a world-first innovation, offering a new solution for drug and health product safety.
In 2014, the company achieved the industrialization of starch-based capsules and soft capsules. The same year, it established Wankang Biochemical Co., Ltd. in Cambodia.
In 2015, the company's Pharmaceutical Excipient Engineering Technology Center passed the CNAS-CL01 Testing Laboratory and CNAS-CL04 Standard Substance/Standard Sample Producer's on-site evaluation in one go. The company's Technical Center was recognized as the 22nd 'National Recognized Enterprise Technical Center' by the National Development and Reform Commission.
In 2016, Erkang Pharmaceutical received honors as one of the 'Most Influential 20 in China's Pharmaceutical Industry' and 'Top 100 Listed Companies Golden Bull Award' for 2015.
In 2017, the 'Research and Development of Plant Starch Capsules and Industrialization' project won the first prize of the Hunan Provincial Science and Technology Progress Award. The same year, the company was designated as a 'Chinese Foreign Aid Training Practice Base' by the Hunan Provincial Department of Commerce.
In 2018, the 'National Pharmaceutical Excipient Engineering Technology Research Center' constructed by Erkang Pharmaceutical passed the acceptance inspection by the National Ministry of Science and Technology.
In 2019, the company was included in the 'Xinhua News Agency National Brand Project'. The same year, the Hunan Erkang Pharmaceutical Co., Ltd. Science and Technology Association was officially founded, marking a new step in the company's scientific research progress.
In 2020, the National Pharmaceutical Excipient Engineering Technology Research Center, built by Erkang Pharmaceutical, became one of the 14 'Variety Guardians' for pharmaceutical excipients.
In 2022, the company was selected as a National Intellectual Property Advantage Enterprise for 2022, contributing to the acceleration of building a strong intellectual property country.
In 2023, it was awarded as a Specialized, Refined, Unique, and Innovative Small and Medium Enterprise in Hunan Province.
In 2024, the company accelerated its global industrial chain layout in the new energy sector.
Our scope includes the supply of starch capsule raw materials, additives & active pharmaceutical ingredients (such as caffeine, sodium citrate, sulfadiazine, and folic acid), as well as innovative green fermentation products (like organic cassava starch and organic cassava syrup). We are dedicated to delivering premium product solutions to meet your diverse needs.
